Last updated 17/05/2022

Primary care rebate schemes (PCRS) are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s).

The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Any decision to accept a PCRS is only made once a clinical decision to approve the use of a medication has been agreed locally.

We are unable to publish the full details of the PCRS because this information is commercially sensitive.

Although there are a number of PCRS available, NHS Salford CCG is currently signed up to the following:

Companies involved Drugs covered Generic names Start date End date

Chiesi Ltd

Clenil Modulite

Belcometasone

Jul-20

Jun-22

Chiesi Ltd

Fostair pMDI

Beclometasone & formoterol

Oct-21

Sep-23

Chiesi Ltd

Fostair NEXThaler

Beclometasone & formoterol

Oct-21

Sep-23

ConvaTec Ltd

Dressings

n/a

Jul-20

Jun-22

Ethypharm UK Ltd

Xaggitin XL

Methlyphenidate

Jun-20

Open-ended

Ethypharm UK Ltd

Pipexus Pramipexole May-22 Open-ended

Ferring Pharmaceuticals

Firmagon

Degarelix

Jan-17

Dec-22

Fontus Health Limited

Luventa XL

Galantamine

Mar-17

Open-ended

Fontus Health Limited

Zaluron XL

Quetiapine

Mar-17

Open-ended

Kyowa Kirin International

Adcal D3

Calcium carbonate & colecalciferol

Apr-17

Open-ended

Merck Serono Limited

Glucophage SR

Metformin

Apr-17

Feb-23

mibe Pharma UK

Dalonev

Calcipotriol & betamethasone

May-21

Open-ended

mibe Pharma UK Solacutan Diclofenac May-22 Open-ended
Mylan Sirdupla Salmeterol & fluticasone Oct -21 March - 23

Sanofi Aventis

Apidra

Insulin glulisine

Apr-17

Jun-22

Sanofi Aventis

Insuman

Isophane insulin

Apr-17

Jun-22

Syri Limited

Zacco

Clobazam

May-21

Apr-23

Takeda UK Limited

Prostap

Leuprorelin acetate

Dec-15

Open-ended